Abbott Diagnostic Products — Total Assets increased by 16.4% to $9.63B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.8%, from $7.84B to $9.63B.
Growth in assets relative to sales may indicate capital expansion, while a decline could suggest asset divestiture or improved asset turnover.
The sum of all assets, including inventory, property, plant, equipment, and intangible assets, specifically attributed t...
Standard balance sheet metric for segment reporting.
abt_segment_diagnostic_products_total_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | 7.7B | 8B | 7.8B | 7.7B | 7.8B | 8.2B | 8.2B | 8.3B | 9.6B |
| QoQ Change | — | +3.7% | -2.7% | -1.1% | +2.1% | +4.3% | +0.3% | +0.9% | +16.4% |
| YoY Change | — | +3.7% | -2.7% | -1.1% | — | — | — | +7.7% | +22.8% |